- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07946861
Intramedullary Nailing for Femoral Shaft Fractures
Comparative Effectiveness Randomized Controlled Trial of Micromotion vs Non-micromotion Intramedullary Nailing for Femoral Shaft Fractures
A randomized controlled trial that is trying to find the best treatment for a severe upper leg (i.e., thigh, also known as femoral shaft) fracture. One type of treatment, which is called micromotion intramedullary (within the hollow center of the bone) nailing, is a type of nail used for thigh fracture treatments that helps to heal the bone by allowing a small amount of controlled movement. Another type, called non-micromotion intramedullary nailing, is also used to treat thigh fractures but does not include this controlled-movement feature. Both treatments are approved by the FDA but have not been directly compared to each other. Participation includes being assigned to receive either a micromotion intramedullary nail or a non-micromotion intramedullary nail. Those that participate will be randomly assigned (like a flip of a coin) to one of those treatment methods and return for standard follow-up visits. In addition to those regular clinical follow-ups, participants will complete some brief surveys/questionnaires while they are in the hospital. Research staff will also look at past medical history.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Indiana
-
Indianapolis, Indiana, Stati Uniti, 46202
- Reclutamento
- Indiana University Health Methodist Hospital
-
Investigatore principale:
- Roman Natoli, MD, PhD
-
Contatto:
- Cora F Mizimakoski, Bachelor of Science
- Numero di telefono: 317-963-5034
- Email: cmizimak@iu.edu
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients aged 18-84 years old inclusive with a femoral shaft fracture deemed appropriate for treatment with an IMN by the treating surgeon
Exclusion Criteria:
- Not within age range
- Planned treatment with dominant implants other than IMN
- Non-ambulatory at baseline
- Fracture needs a planned-staged secondary procedure for bone defects (e.g., Masquelet)
- Any previous surgery on the index site
- Fracture fixation >28 days from injury
- Fractures that the treating surgeon indicates require any additional fixation that spans the fracture. These patients will be late ineligible
- Patients with a history of infection or a current active infection at the surgical site
- Patients undergoing revision surgery following primary fixation
- Patients undergoing femoral nailing for a pathological fracture
- Patients undergoing bone transport over an intramedullary nail
- Non-English or Non-Spanish speaking
- Prisoners or impending incarceration
- Patients unwilling or unable to participate in study protocol or follow up in the IU system for 12 months
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Standard Intramedullary Nailing
|
A rod inserted into the hollow center of a long bone to hold a broken bone in place while it heals. |
|
Sperimentale: OrthoXel Micromotion Intramedullary Nail
|
An intramedullary nail that allows for controlled axial micromotion. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Superiority of micromotion nailing over non-micromotion IMN according to a composite outcome using a win ratio reflective of improved femoral shaft fracture healing
Lasso di tempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Iindividual levels of the win-ratio pyramid between the micromotion nailing and non-micromotion nailing groups.
Lasso di tempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Superiority of micromotion nailing in a subgroup of patients at high baseline risk for nonunion.
Lasso di tempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Number of patients with Adverse Events and Complications between the Micromotion nail and standard of care intramedullary nails.
Lasso di tempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Change in daily step count from pre-injury baseline between the micromotion nailing and non-micromotion nailing groups.
Lasso di tempo: From enrollment to end of treatment at about a year.
|
Daily step count, measured in steps per day, will be obtained from the Apple Health app on the participant's iPhone. Participants will download the OrthoSteps app once to transfer their Apple Health data to the study team. Step counts will be assessed at the pre-injury baseline and at each post-injury follow-up. |
From enrollment to end of treatment at about a year.
|
|
Gait balance between the two groups as calculated by the GaitMap.
Lasso di tempo: From enrollment to end of treatment at about a year
|
From enrollment to end of treatment at about a year
|
|
|
Walking speed using a GaitMap
Lasso di tempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Modified Radiographic union scores for femoral shaft fractures
Lasso di tempo: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Roman Natoli, MD, PhD, Indiana University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- 29753
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .